Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report / J. Salmanton-García, F. Marchesi, A. Glenthøj, Y.M. Bilgin, J. van Praet, J. Dávila-Valls, S. Martín-Pérez, J. Labrador, J. van Doesum, I. Falces-Romero, F. Farina, M. Schönlein, M. Chanut, V. Petzer, I. Espigado, M. Dargenio, A. Aujayeb, U. Sili, L. Serrano, L.I. Pinczés, N. de Jonge, A. Soto-Silva, C. Buquicchio, L. Prezioso, M. Marchetti, S. Meers, A. Busca, P. Corradini, M. Hoenigl, P. Koehler, L. Rahimli, G.M. Çolak, E. Arellano, D. Wolf, S. Gräfe, E. Ammatuna, C. Berg Venemyr, O.A. Cornely, L. Pagano. - In: HEMASPHERE. - ISSN 2572-9241. - 6:11(2022), pp. e789.1-e789.4. [10.1097/HS9.0000000000000789]
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
F. Farina;P. Corradini;
2022
File | Dimensione | Formato | |
---|---|---|---|
hs9-6-e789.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
301.1 kB
Formato
Adobe PDF
|
301.1 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.